University of California San Francisco
Hematologists and oncologists from UC San Francisco shared research results and clinical guidance at the world’s premier meeting for malignant and non-malignant hematology at the American Society of Hematology’s (ASH) 67th Annual Meeting and Exposition. This year’s meeting was held in Orlando, Dec. 6-9.
Millions of people in the U.S. and around the world are living with hepatitis C virus (HCV). But over the past decade, direct-acting antivirals (DAA) have proven effective against HCV, curing more than 95% of those who complete treatment. Traditionally, patients have had to wait at least 12 weeks after finishing treatment to find out if they are cured.
Aortic stenosis is a narrowing of the aortic valve which connects the heart to the rest of the body. It affects millions of people and can be fatal if left untreated. At present, there are no effective medical therapies to prevent or slow its progression. The only effective treatments are surgery or percutaneous valve replacement when the valve has become severely narrowed.
Recently, common genetic variants have been linked to the clinical diagnosis of aortic stenosis in population genetic studies.